- Home
- DVS vs TKNO Comparison
DVS vs TKNO Comparison
Compare DVS & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVS
- TKNO
- Stock Information
- Founded
- DVS 2011
- TKNO 1996
- Country
- DVS Canada
- TKNO United States
- Employees
- DVS N/A
- TKNO N/A
- Industry
- DVS
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- DVS
- TKNO Health Care
- Exchange
- DVS Nasdaq
- TKNO Nasdaq
- Market Cap
- DVS 401.8M
- TKNO 340.9M
- IPO Year
- DVS N/A
- TKNO 2021
- Fundamental
- Price
- DVS $4.13
- TKNO $4.49
- Analyst Decision
- DVS
- TKNO
- Analyst Count
- DVS 0
- TKNO 0
- Target Price
- DVS N/A
- TKNO N/A
- AVG Volume (30 Days)
- DVS 775.6K
- TKNO 190.3K
- Earning Date
- DVS 11-21-2025
- TKNO 11-06-2025
- Dividend Yield
- DVS N/A
- TKNO N/A
- EPS Growth
- DVS N/A
- TKNO N/A
- EPS
- DVS N/A
- TKNO N/A
- Revenue
- DVS N/A
- TKNO $39,801,000.00
- Revenue This Year
- DVS N/A
- TKNO $9.52
- Revenue Next Year
- DVS N/A
- TKNO $15.20
- P/E Ratio
- DVS N/A
- TKNO N/A
- Revenue Growth
- DVS N/A
- TKNO 9.50
- 52 Week Low
- DVS $2.48
- TKNO $3.94
- 52 Week High
- DVS $5.38
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- DVS 46.54
- TKNO 38.48
- Support Level
- DVS $4.00
- TKNO $4.26
- Resistance Level
- DVS $4.49
- TKNO $5.00
- Average True Range (ATR)
- DVS 0.22
- TKNO 0.38
- MACD
- DVS 0.03
- TKNO -0.09
- Stochastic Oscillator
- DVS 45.98
- TKNO 13.83
About DVS Dolly Varden Silver Corporation Common Shares
Dolly Varden Silver Corp is a mineral exploration company. The company's primary business is the acquisition, exploration, evaluation, and development of exploration and evaluation assets. It is focused on exploration advancing the Kitsault Valley Project, which includes the Dolly Varden property and the Homestake Ridge property located in the Golden Triangle of British Columbia, Canada.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.